HK31697A - Method for the diagnosis of blood coagulation disorders - Google Patents

Method for the diagnosis of blood coagulation disorders

Info

Publication number
HK31697A
HK31697A HK31697A HK31697A HK31697A HK 31697 A HK31697 A HK 31697A HK 31697 A HK31697 A HK 31697A HK 31697 A HK31697 A HK 31697A HK 31697 A HK31697 A HK 31697A
Authority
HK
Hong Kong
Prior art keywords
diagnosis
conversion
sample
rate
blood coagulation
Prior art date
Application number
HK31697A
Other languages
English (en)
Inventor
Bjoern Dahlbaeck
Original Assignee
Bjoern Dahlbaeck
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26661244&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK31697(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from SE9103332A external-priority patent/SE470274B/sv
Application filed by Bjoern Dahlbaeck filed Critical Bjoern Dahlbaeck
Publication of HK31697A publication Critical patent/HK31697A/xx

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/56—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving blood clotting factors, e.g. involving thrombin, thromboplastin, fibrinogen
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96433—Serine endopeptidases (3.4.21)
    • G01N2333/96441—Serine endopeptidases (3.4.21) with definite EC number
    • G01N2333/96461—Protein C (3.4.21.69)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
HK31697A 1991-11-13 1997-03-13 Method for the diagnosis of blood coagulation disorders HK31697A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9103332A SE470274B (sv) 1991-11-13 1991-11-13 Användning av en in vitro-metod för diagnos av blodkoagulationssjukdomar
US81130391A 1991-12-20 1991-12-20
PCT/SE1992/000310 WO1993010261A1 (en) 1991-11-13 1992-05-13 Method for the diagnosis of blood coagulation disorders

Publications (1)

Publication Number Publication Date
HK31697A true HK31697A (en) 1997-03-21

Family

ID=26661244

Family Applications (1)

Application Number Title Priority Date Filing Date
HK31697A HK31697A (en) 1991-11-13 1997-03-13 Method for the diagnosis of blood coagulation disorders

Country Status (10)

Country Link
EP (1) EP0608235B2 (el)
JP (1) JP2562000B2 (el)
AT (1) ATE132909T1 (el)
CA (1) CA2119761C (el)
DE (2) DE69207607T3 (el)
DK (1) DK0608235T4 (el)
ES (1) ES2081618T5 (el)
GR (1) GR3018646T3 (el)
HK (1) HK31697A (el)
WO (1) WO1993010261A1 (el)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4229933A1 (de) * 1992-09-08 1994-03-10 Max Planck Gesellschaft Verfahren zur Bestimmung von Thrombose verursachenden Lupus-anticoagulant-Antikörpern
PL181102B1 (pl) * 1993-01-29 2001-05-31 Dahlbaeck Bjoern Sposób oznaczania w próbce funkcjonalnej aktywności wybranego składnika koagulacji krwi
US5472852A (en) * 1993-09-15 1995-12-05 Oklahoma Medical Research Foundation Assay for detection of selective Protein C inhibition by patients
DE59410041D1 (de) * 1993-12-03 2002-03-21 Baxter Ag Test zur Bestimmung der Empfindlichkeit gegenüber aktiviertem Protein C
EP0696325B1 (en) 1994-02-14 1998-05-13 Rijksuniversiteit Leiden A method for screening for the presence of a genetic defect associated with thrombosis and/or poor anticoagulant response to activated protein c
DE4418635C2 (de) * 1994-05-27 1997-07-24 Immuno Ag Pharmazeutische Zusammensetzung zur Vorbeugung und Behandlung von Blutgerinnungsstörungen
AUPM731394A0 (en) * 1994-08-05 1994-09-01 Life Therapeutics Limited Improved activated protein c resistance test
ES2154703T5 (es) † 1994-11-10 2008-02-01 Dade Behring Marburg Gmbh Procedimiento para la deteccion especifica de un factor de coagulacion v activado con una estabilidad elevada frente a proteina c activada.
US5705395A (en) * 1994-11-14 1998-01-06 The Scripps Research Institute Method for diagnosis of thrombotic disorders
US6867045B1 (en) 1994-11-14 2005-03-15 The Scripps Research Institute Method for diagnosis of thrombotic disorders
DE69520725T3 (de) † 1994-12-23 2005-11-17 Diagnostic Reagents Ltd., Thame Verfahren zur Diagnose von Blutgerinnungsstörungen
US5874256A (en) * 1995-06-06 1999-02-23 Rijks Universiteit Leiden Method for diagnosing an increased risk for thrombosis or a genetic defect causing thrombosis and kit for use with the same
US5780255A (en) * 1995-06-09 1998-07-14 Instrumentation Laboratory, S.P.A. Protein C pathway screening test
AT403289B (de) * 1996-01-30 1997-12-29 Immuno Ag Verfahren zur herstellung eines standardisierten plasmapools für diagnostische zwecke
US6379975B1 (en) 1996-11-27 2002-04-30 T.A.C. Thrombosis And Coagulation Aktiebolag Methods and reagents for determining protein S
FR2764389B1 (fr) * 1997-06-06 1999-08-06 Stago Diagnostica Utilisation de venin de crotalus viridis helleri, procede et necessaire pour la determination de la reactivite de la proteine c activee
DE19724239A1 (de) * 1997-06-09 1998-12-10 Max Planck Gesellschaft Dysprothrombinämie
US6743596B1 (en) * 2000-10-27 2004-06-01 Biomerieux, Inc. Method of determining global coagulability hemostatic potential
US6855509B2 (en) 2000-12-19 2005-02-15 Instrumentation Laboratory Company Protein S functional assay and kit therefor
US7696309B2 (en) * 2006-10-23 2010-04-13 The Brigham And Women's Hospital, Inc. Protease resistant mutants of stromal cell derived factor-1 in the repair of tissue damage
AU2012268078B2 (en) 2011-06-07 2017-06-01 Mesoblast International Sarl Methods for repairing tissue damage using protease-resistant mutants of stromal cell derived Factor-1
RU2518247C2 (ru) * 2011-07-26 2014-06-10 Общество с ограниченной ответственностью "ГемаКор Лабс" (ООО "ГемаКор Лабс") Способ определения пространственно-временного распределения активности протеолитического фермента в гетерогенной системе, устройство для реализации указанного способа и способ диагностики нарушений системы гемостаза по изменению пространственно-временного распределения активности протеолитического фермента в гетерогенной системе
WO2016123163A2 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease
RU2752776C1 (ru) * 2020-12-16 2021-08-03 Федеральное государственное бюджетное образовательное учреждение высшего образования "Алтайский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ определения длительности тромбопрофилактики низкомолекулярным гепарином после абдоминального родоразрешения у носителей мутации Лейден, генотип F5 G1691A

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5051357A (en) * 1989-07-14 1991-09-24 Board Of Trustees Operating Michigan State University Method and assay using inactivation of factors Va and VIIIa by activated Protein C to diagnose thrombic disease or assay for Protein C and kit therefor
WO1991001383A1 (en) * 1989-07-14 1991-02-07 Michigan State University Method for diagnosing blood clotting disorders
SE464135B (sv) † 1989-07-14 1991-03-11 Kabivitrum Ab Foerfarande foer bestaemning av funktionell aktivitet av fritt protein s eller protein c i ett plasmaprov
US5169786A (en) * 1989-12-19 1992-12-08 Ortho Diagnostic Systems, Inc. Method of determining levels of extrinsic and intrinsic clotting factors and protein c
ES2154703T5 (es) † 1994-11-10 2008-02-01 Dade Behring Marburg Gmbh Procedimiento para la deteccion especifica de un factor de coagulacion v activado con una estabilidad elevada frente a proteina c activada.
US5705395A (en) † 1994-11-14 1998-01-06 The Scripps Research Institute Method for diagnosis of thrombotic disorders

Also Published As

Publication number Publication date
EP0608235B2 (en) 2005-05-04
WO1993010261A1 (en) 1993-05-27
JPH07501217A (ja) 1995-02-09
ATE132909T1 (de) 1996-01-15
EP0608235B1 (en) 1996-01-10
CA2119761C (en) 1997-12-16
JP2562000B2 (ja) 1996-12-11
AU666484B2 (en) 1996-02-15
EP0608235A1 (en) 1994-08-03
AU2198092A (en) 1993-06-15
ES2081618T5 (es) 2005-09-01
DK0608235T4 (da) 2005-05-30
CA2119761A1 (en) 1993-05-27
GR3018646T3 (en) 1996-04-30
ES2081618T3 (es) 1996-03-16
DK0608235T3 (da) 1996-02-12
DE608235T1 (de) 1994-12-22
DE69207607D1 (de) 1996-02-22
DE69207607T3 (de) 2006-07-06
DE69207607T2 (de) 1996-06-20

Similar Documents

Publication Publication Date Title
GR3018646T3 (en) Method for the diagnosis of blood coagulation disorders.
WO1997012992A3 (en) Diagnosis method for a disease caused by a frameshift mutation in a gene and reagents therefore
HK1026720A1 (en) Non-invasive prenatal diagnosis
CA2282746A1 (en) Prediction of coronary artery disease
CA2239692A1 (en) Diagnosis and treatment of aur-1 and/or aur-2 related disorders
EP0911390A3 (en) Protein kinases as tools for the diagnosis and treatment of Alzheimer's disease
WO2002094864A3 (en) Human cdnas and proteins and uses thereof
WO1999037788A3 (en) Diagnosis and treatment of aur1 and/or aur2 related disorders
ES2151880T3 (es) Antagonistas de proteina de coagulacion de la sangre y sus utilizaciones.
CA2051374A1 (en) Process for the separation and purification of sialyl transferases
EP1221619A3 (en) Method for diagnosing benign prostatic diseases
AU7800087A (en) Polypeptide useful for the alleviation, treatment and diagnosis of autoimmune diseases, especially arthritic conditions etc.,
WO2003024308A3 (en) Methods of assaying connective tissue growth factor
AU2742892A (en) An anticoagulant substance obtained from urine
PT948604E (pt) Produtos e metodos relacionados com pyk2
ES516496A0 (es) "procedimiento para la determinacion de hemoglobina glucosilada".
Lorentz et al. Recommendation for the determination of the catalytic concentration of lactate dehydrogenase at 37 degrees C. Standardization Committee of the German Society for Clinical Chemistry, Enzyme Working Group of the German Society for Clinical Chemistry
WO2003046180A3 (en) Human cdnas and proteins and uses thereof
AU4850596A (en) Process and installation for the production of confectionary mass from at least the components milk proteins, sugar, glucose, fat and water
WO1999058098A8 (en) HUMAN ANTITHROMBIN IIIs AND METHODS RELATED THERETO
WO1998051782A3 (en) Human 3-hydroxyisobutyryl-coenzyme a hydrolase
DE69734890D1 (de) Rdgb-proteine
AU5736899A (en) A mutant of tissue factor pathway inhibitor, dna sequence and use for detecting thrombotic disorders
AU2713288A (en) Human-type serum obtained from fractions resulting from the fractionation of human blood or serum, process for its preparation and laboratory reaction containing said serum
DK0587090T3 (da) Fremgangsmåde til bestemmelse af thromboseforårsagende lupus-antikoagulat-antistoffer.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20040511